Welcome to our dedicated page for Nuclear Vision news (Ticker: GDIGF), a resource for investors and traders seeking the latest updates and insights on Nuclear Vision stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nuclear Vision's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nuclear Vision's position in the market.
Nuclear Vision (GDIGF) increased its private placement to 24,000,000 Units at $0.25 per Unit, raising up to $6,000,000. Each Unit includes one common share and one-half warrant; warrants are exercisable for 24 months at $0.375 (months 0–12) and $0.50 (months 13–24). The company said proceeds will fund advancement of the Svabovce and Michalova manganese projects in Slovakia and for general working capital. Securities will be subject to a statutory four-month and one day hold; finder’s fees may apply. Mr. Eric Sprott indicated intent to participate for up to $2,000,000.
FAQ
What is the current stock price of Nuclear Vision (GDIGF)?
